Aethlon Medical Inc

AEMD

Company Profile

  • Business description

    Aethlon Medical Inc is a medical therapeutic company focused on developing the Hemopurifier (HP), a clinical-stage investigational immunotherapeutic device designed to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation and other disease states in which extracellular vesicles (EVs) contribute to disease progression. The Hemopurifier utilizes a proprietary lectin-based technology to bind and remove enveloped viruses and EVs from biological fluids. EVs have been associated with immune suppression, metastasis, and resistance to therapy in cancer, as well as progression of severe infectious diseases. The Company operates as a single reportable segment.

  • Contact

    11555 Sorrento Valley Road
    Suite 203
    San DiegoCA92121
    USA

    T: +1 619 941-0360

    E: [email protected]

    https://www.aethlonmedical.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 March 2027

    Employees

    9

Stocks News & Analysis

stocks

SpaceX is scaling AI infrastructure on earth, data centers in space might be next

Our view on the first results as a publicly traded company.
stocks

Investors too optimistic about overvalued ASX share

Upgraded first-half revenue guidance at the upper end of the previously announced range.
stocks

Restructuring at big four bank

Job cuts create capacity to invest as revenue growth slows.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,917.1039.50-0.44%
CAC 407,807.02114.66-1.45%
DAX 4025,371.10273.94-1.07%
Dow JONES (US)52,856.09360.210.69%
FTSE 10010,700.2552.63-0.49%
HKSE22,934.68717.19-3.03%
NASDAQ26,702.86278.041.05%
Nikkei 22562,907.841,713.40-2.65%
NZX 50 Index13,746.8414.45-0.11%
S&P 5007,757.1744.600.58%
S&P/ASX 2008,793.2038.10-0.43%
SSE Composite Index3,658.0355.00-1.48%

Market Movers